Therapeutics

Our lawyers combine their knowledge of finance, corporate governance, regulatory affairs, patents, intellectual property, licensing and dispute resolution and combine it with their experience in therapeutics to provide unique counsel for our clients. We regularly advise foreign clients on all areas of U.S. laws and regulations, as well as strategic steps to protect business objectives in the U.S. and abroad. Our clients include venture capital firms, health care corporations, academic institutions and industrial firms. 

Representative Client Work

  • Developed and negotiated complex licensing, manufacturing, distribution and joint venture agreements for a life sciences company seeking to collaborate in the research and development of antibodies for human therapeutic uses
  • Represented life sciences company in connection with the strategic development and prosecution of its patent portfolio related to gene suppression and replacement
  • Represented a foreign life sciences company in connection with a serious adverse event following administration of the company's drug during a Phase III clinical trial
  • Represented a generic drug manufacturer in negotiating a "schedule contract" with the Department of Veterans Affairs
  • Represented a publicly-traded life sciences company in a patent infringement action relating to cell preservative fluids
  • Represent an investment bank in connection with the analysis of prominent pharmaceutical litigation related to paragraph IV challenges by generic drug companies
  • Represented a publicly-traded life sciences company in a license/trade secret dispute relating to methods to treat mitochondrial disease using uridine analogs
  • Represented a life sciences company with ongoing strategic planning in connection with the development of technology licensing relationships with big pharma and leading educational institutions
  • Represented a publicly-traded life sciences company with 43 subsidiaries worldwide on patent licensing, technology transfer, distribution agreements, terms and conditions of sale and related matters
  • Represented an acquisition group in an offer to a public pharmaceutical manufacturer for a division that primarily manufactured controlled substances
  • Represent a medical device company in connection with the strategic development and prosecution of its patent portfolio related to non-CFC aerosols for the delivery of pharmaceuticals